{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:08:10Z","timestamp":1789546090043,"version":"build-2803163510"},"reference-count":30,"publisher":"The Endocrine Society","issue":"10","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000082","name":"Division of Graduate Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000082","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Variability exists in the use of radioactive iodine (RAI) treatment in intermediate-risk (IR) thyroid cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The study surveyed clinicians about their use of RAI in theoretical cases of patients with IR thyroid cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A survey presented patient cases with pathology results and 2 variations consisting of baseline thyroglobulin levels of \u22645 and &amp;gt;5\u2005ng\/mL. Respondents were queried as to their use of RAI therapy in each case. Univariate Bayesian cumulative ordinal regression models were used to evaluate the relationships between selected predictors and the response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Online survey.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>American Thyroid Association members.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Participants responded regarding their management of 15 patient cases of IR thyroid cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Use of RAI therapy, consisting of no RAI or doses of \u223c30, 40 to 74, 75 to 100, or &amp;gt;100\u2005mCi.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Members were surveyed in May and June, 2024. Using matched vignettes, respondents were more likely to recommend RAI doses of \u226530\u2005mCi and more likely to recommend higher RAI doses in general when thyroglobulin levels were &amp;gt;5\u2005ng\/mL compared with \u22645\u2005ng\/mL (odds ratios [ORs] 2.89-18.28). Examining unadjusted associations within the case scenarios presented, the presence of lymph nodes measuring 0.2-3\u2005cm, more than 5 positive lymph nodes, and lateral lymph nodes were associated with higher RAI dose recommendations (unadjusted ORs 2.33-26.16).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Within the IR category, there were specific pathology and biochemical findings associated with greater likelihood of the clinician recommending RAI therapy. These findings may be instructive in understanding how these features are perceived to add to the risk of thyroid cancer recurrence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/jendso\/bvag202","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:20:58Z","timestamp":1788412858000},"source":"Crossref","is-referenced-by-count":0,"title":["Intermediate risk thyroid cancer management: physician survey"],"prefix":"10.1210","volume":"10","author":[{"given":"Annu R","family":"Suresh","sequence":"first","affiliation":[{"name":"Internal Medicine Residency Program, Medstar Georgetown University Hospital , Washington, DC 20007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Kung","sequence":"additional","affiliation":[{"name":"Internal Medicine Residency Program, Medstar Georgetown University Hospital , Washington, DC 20007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0552-0246","authenticated-orcid":false,"given":"Jiling","family":"Chou","sequence":"additional","affiliation":[{"name":"MedStar Center for Biostatistics, Informatics, and Data Science (CBIDS), MedStar Health Research Institute , Hyattsville, MD 20782, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2238-2666","authenticated-orcid":false,"given":"Jacqueline","family":"Jonklaas","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Georgetown University , Washington, DC 20007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"issue":"9","key":"2026091603523810600_bvag202-B1","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1210\/JC.2015-1346","article-title":"Long-term outcomes following therapy in differentiated thyroid carcinoma: NTCTCS registry analysis 1987-2012","volume":"100","author":"Carhill","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026091603523810600_bvag202-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"issue":"12","key":"2026091603523810600_bvag202-B3","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.6004\/jnccn.2014.0169","article-title":"Thyroid carcinoma, version 2.2014","volume":"12","author":"Tuttle","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"2026091603523810600_bvag202-B4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American thyroid association management guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"issue":"10","key":"2026091603523810600_bvag202-B5","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1089\/thy.2018.0186","article-title":"Using the American Thyroid Association risk-stratification system to refine and individualize the American Joint Committee on Cancer eighth edition disease-specific survival estimates in differentiated thyroid cancer","volume":"28","author":"Ghaznavi","year":"2018","journal-title":"Thyroid"},{"issue":"6","key":"2026091603523810600_bvag202-B6","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.surg.2005.09.021","article-title":"Radioactive iodine offers survival improvement in patients with follicular carcinoma of the thyroid","volume":"138","author":"Podnos","year":"2005","journal-title":"Surgery"},{"issue":"1","key":"2026091603523810600_bvag202-B7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jso.20656","article-title":"Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope","volume":"96","author":"Podnos","year":"2007","journal-title":"J Surg Oncol"},{"issue":"6","key":"2026091603523810600_bvag202-B8","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.surg.2012.08.034","article-title":"Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer\u2014is there a need for radioactive iodine therapy?","volume":"152","author":"Ibrahimpasic","year":"2012","journal-title":"Surgery"},{"issue":"17","key":"2026091603523810600_bvag202-B9","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16173096","article-title":"Decision variables for the use of radioactive iodine in patients with thyroid cancer at intermediate risk of recurrence","volume":"16","author":"Newman","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2026091603523810600_bvag202-B10","first-page":"55","article-title":"Differentiated and anaplastic thyroid carcinoma: major changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"68","author":"Perrier","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"2026091603523810600_bvag202-B11","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1210\/jc.2019-00177","article-title":"Risk stratification in differentiated thyroid cancer: from detection to final follow-up","volume":"104","author":"Tuttle","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026091603523810600_bvag202-B12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/thy.2014.0298","article-title":"Use of evidence-based guidelines reduces radioactive iodine treatment in patients with low-risk differentiated thyroid cancer","volume":"25","author":"Sacks","year":"2015","journal-title":"Thyroid"},{"issue":"2","key":"2026091603523810600_bvag202-B13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00268-017-4308-9","article-title":"Less is more: the impact of multidisciplinary thyroid conference on the treatment of well-differentiated thyroid carcinoma","volume":"42","author":"Moore","year":"2018","journal-title":"World J Surg"},{"issue":"6","key":"2026091603523810600_bvag202-B14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1089\/thy.2012.0307","article-title":"The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on memorial sloan-kettering cancer center risk group stratification","volume":"23","author":"Nixon","year":"2013","journal-title":"Thyroid"},{"issue":"10","key":"2026091603523810600_bvag202-B15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1530\/ERC-19-0292","article-title":"Radioactive iodine in differentiated thyroid cancer: a national database perspective","volume":"26","author":"Orosco","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"2026091603523810600_bvag202-B16","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s12020-024-04027-4","article-title":"Consider or not consider: the unsolved question on the use of radioactive iodine for differentiated thyroid cancer with low to intermediate risk of recurrence","volume":"87","author":"Malandrino","year":"2025","journal-title":"Endocrine"},{"issue":"9","key":"2026091603523810600_bvag202-B17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.eprac.2024.06.003","article-title":"Controversies in the management of intermediate-risk differentiated thyroid cancer","volume":"30","author":"Toro-Tobon","year":"2024","journal-title":"Endocr Pract"},{"issue":"3","key":"2026091603523810600_bvag202-B18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ejso.2017.04.002","article-title":"Selective use of radioactive iodine (RAI) in thyroid cancer: no longer \u201cone size fits all\u201d","volume":"44","author":"Marti","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"2026091603523810600_bvag202-B19","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1210\/jc.2012-3355","article-title":"Variation in the management of thyroid cancer","volume":"98","author":"Haymart","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026091603523810600_bvag202-B20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/thy.2012.0380","article-title":"Factors that influence radioactive iodine use for thyroid cancer","volume":"23","author":"Papaleontiou","year":"2013","journal-title":"Thyroid"},{"issue":"1","key":"2026091603523810600_bvag202-B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v080.i01","article-title":"Brms: an R package for Bayesian multilevel models using stan","volume":"80","author":"Burkner","year":"2017","journal-title":"J Stat Softw"},{"issue":"5","key":"2026091603523810600_bvag202-B22","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s11222-016-9696-4","article-title":"Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC","volume":"27","author":"Vehtari","year":"2017","journal-title":"Stat Comput"},{"key":"2026091603523810600_bvag202-B23","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2016"},{"issue":"3","key":"2026091603523810600_bvag202-B24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4103\/jcrt.JCRT_1011_16","article-title":"The prognostic factors for clinical N1b patients in thyroid papillary carcinoma","volume":"15","author":"Yuksel","year":"2019","journal-title":"J Cancer Res Ther"},{"key":"2026091603523810600_bvag202-B25","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1158826","article-title":"Assessing the role of central lymph node ratio in predicting recurrence in N1a low-to-intermediate risk papillary thyroid carcinoma","volume":"14","author":"Ma","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2026091603523810600_bvag202-B26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1089\/thy.2017.0334","article-title":"Nodal factors predictive of recurrence after thyroidectomy and neck dissection for papillary thyroid carcinoma","volume":"28","author":"Nam","year":"2018","journal-title":"Thyroid"},{"issue":"2","key":"2026091603523810600_bvag202-B27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1001\/jamaoto.2017.2416","article-title":"Association of lymph node density with survival of patients with papillary thyroid cancer","volume":"144","author":"Amit","year":"2018","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"1","key":"2026091603523810600_bvag202-B28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12893-019-0541-5","article-title":"Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a","volume":"19","author":"Ryu","year":"2019","journal-title":"BMC Surg"},{"issue":"6","key":"2026091603523810600_bvag202-B29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1089\/thy.2021.0666","article-title":"Serum thyroglobulin measurement following surgery without radioactive iodine for differentiated thyroid cancer: a systematic review","volume":"32","author":"Chou","year":"2022","journal-title":"Thyroid"},{"key":"2026091603523810600_bvag202-B30","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2025.104001","article-title":"Role of post-operative thyroglobulin in predicting disease-recurrence in differentiated thyroid cancer","volume":"50","author":"Cheng","year":"2026","journal-title":"Clin Oncol (R Coll Radiol)"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvag202\/70934920\/bvag202.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/10\/bvag202\/70934920\/bvag202.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/10\/bvag202\/70934920\/bvag202.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:52:54Z","timestamp":1789545174000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvag202\/8780869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,9,3]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvag202","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,3]]},"article-number":"bvag202"}}